Back to Trades
Total Value
$34.8M
Net $34.8M sold
Filing Date
Jun 25, 2026
22 transactions
Sales
$34.8M
22 transactions
Trade Summary
On Jun 25, 2026, Booth Bruce, Insider, sold $34.8M of Kymera Therapeutics, Inc. (KYMR) across 22 transactions. The filing covers Common Stock and reflects net selling of $34.8M. Reported prices ranged from $119.71 to $129.61. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Kymera Therapeutics, Inc.
- Ticker Symbol
- KYMR
- CIK
- 0001815442
Insider Information
- Name
- Booth Bruce
- Role
- Insider
- Location
- WATERTOWN, MA
Filing Details
- Filing Date
- Jun 25, 2026
- Transaction Date
- Jun 23, 2026
- Accession Number
- 0001451612-26-000016
- Form Type
- 4
- Net Trading Amount
- -$34.8M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | 37,179 | $119.71 | Sale | $4.5M |
| Jun 25, 2026 | Common Stock | 112,299 | $120.66 | Sale | $13.5M |
| Jun 25, 2026 | Common Stock | 40,774 | $121.38 | Sale | $4.9M |
| Jun 25, 2026 | Common Stock | 4,977 | $122.67 | Sale | $610.5K |
| Jun 25, 2026 | Common Stock | 10,860 | $123.62 | Sale | $1.3M |
| Jun 25, 2026 | Common Stock | 11,711 | $124.61 | Sale | $1.5M |
| Jun 25, 2026 | Common Stock | 3,716 | $125.82 | Sale | $467.5K |
| Jun 25, 2026 | Common Stock | 1,609 | $126.71 | Sale | $203.9K |
| Jun 25, 2026 | Common Stock | 25,075 | $127.37 | Sale | $3.2M |
| Jun 25, 2026 | Common Stock | 2,197 | $128.69 | Sale | $282.7K |
| Jun 25, 2026 | Common Stock | 337 | $129.61 | Sale | $43.7K |
| Jun 25, 2026 | Common Stock | 5,144 | $119.71 | Sale | $615.8K |
| Jun 25, 2026 | Common Stock | 15,660 | $120.66 | Sale | $1.9M |
| Jun 25, 2026 | Common Stock | 5,689 | $121.38 | Sale | $690.5K |
| Jun 25, 2026 | Common Stock | 698 | $122.67 | Sale | $85.6K |
| Jun 25, 2026 | Common Stock | 1,517 | $123.62 | Sale | $187.5K |
| Jun 25, 2026 | Common Stock | 1,639 | $124.61 | Sale | $204.2K |
| Jun 25, 2026 | Common Stock | 522 | $125.82 | Sale | $65.7K |
| Jun 25, 2026 | Common Stock | 223 | $126.71 | Sale | $28.3K |
| Jun 25, 2026 | Common Stock | 3,507 | $127.37 | Sale | $446.7K |
| Jun 25, 2026 | Common Stock | 305 | $128.69 | Sale | $39.3K |
| Jun 25, 2026 | Common Stock | 46 | $129.61 | Sale | $6.0K |
Want live alerts when Booth Bruce trades again?
Download Insider Trades to track KYMR, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.08 to $120.0798 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (2) and (4) through (13).
- (F3)These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.08 to $121.0794 inclusive.
- (F5)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.08 to $122.0731 inclusive.
- (F6)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.0858 to $123.08 inclusive.
- (F7)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.09 to $124.08 inclusive.
- (F8)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.09 to $125.0292 inclusive.
- (F9)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.1194 to $126.115 inclusive.
- (F10)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.13 to $127.0511 inclusive.
- (F11)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.30 to $128.2975 inclusive.
- (F12)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.3008 to $129.2819 inclusive.
- (F13)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.3041 to $130.05 inclusive.
- (F14)The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. ("AVOF"). Atlas Venture Associates Opportunity I, L.P. ("AVAO LP") is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC ("AVAO LLC") is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.